Pascal Koenig

Resistell AG proposes a new approach to determine bacterial resistance to antibiotics, which significantly reduces the time to results and thus benefits the patient and the healthcare system. The company was founded by Danuta Cichocka, Giovanni Dietler and Sandor Kasas on April 4, 2018 and is headquartered in Basel, Switzerland.

Assura SA provides health insurance. The firm offers basic health insurance, extended care services, dental care, vacation and travel insurance, supplementary, accident insurance and prenatal insurance. The company was founded in 1978 and is headquartered in Pully, Switzerland.

Part of Roche Holding AG, Roche Diagnostics GmbH is a German company that develops innovative medicines, treatments, and diagnostics. The company is based in Mannheim, Germany. The CEOs of the company are Claudia Fleischer, Claus Haberda, Clemens Schmid. Roche Diagnostics was acquired by Roche Holding AG on January 01, 1999.

NOMOQ AG provides printing services for beverage cans. The private company is based in Zurich, Switzerland. The Swiss company was founded by Peter Stein and Patrick Schweizer, with Peter Stein serving as CEO since incorporation.

NOMOQ GmbH digitally prints aluminum cans for any kind of beverage with high-quality and vibrant colors. The company is based in Kirchheimbolanden, Germany. The German company provides craft breweries and beverage producers with the ability to print as many cans as they want, with no minimum order quantity. NOMOQ's mission is to serve a creative community of craft drink producers and unlock their creativity with finely printed aluminum cans without minimum order quantities. NOMOQ was founded in 2021 by Peter Stein, Albrecht Haake, Gabriela Andrei, and Patrick Schweizer, with Peter Stein serving as the CEO since 2021.

Calliditas Therapeutics Suisse SA engages in the development of NOX therapies. Its platform enables the identification of orally available small-molecules that selectively inhibit specific NOX enzymes, which amplify multiple disease processes such as fibrosis, inflammation, pain processing, cancer development, and neurodegeneration. The company was founded Chihiro Yabe, Robert A. Clark, David Lambeth, and Karl-Heinz Krause in 2006 and is headquartered in Geneva, Switzerland.

Privilège Ventures SA (Privilège Ventures) is a venture capital subsidiary of Privilège Management SA founded in 2016 by Jacqueline Ruedin Rüsch. The firm is headquartered in Lugano, Switzerland.